Startups and venture capital
Evonik raises earnings outlook after third-quarter operating profit jumps 40%
The German specialty chemicals group reported adjusted EBITDA of €629 million and lifted its 2026 outlook, citing stronger demand amid supply disruptions linked to the Middle East crisis.